Long noncoding RNA <i>Chast</i> promotes cardiac remodeling
Janika Viereck(Medizinische Hochschule Hannover), Thomas Thum(Medizinische Hochschule Hannover), Ariana Foinquinos(Medizinische Hochschule Hannover), Tobias Maetzig(Medizinische Hochschule Hannover), Janet Remke(Medizinische Hochschule Hannover), Ke Xiao(Nanchang University), Kristian Scherf(Integrierte Forschungs- und Behandlungszentren), Robert Zweigerdt(Medizinische Hochschule Hannover), León J. De Windt(Maastricht University), Emiliano Bolesani(Medizinische Hochschule Hannover), Axel Schambach(Boston Children's Hospital), Sándor Bátkai(National Institutes of Health), Marcus Dittrich(University of Würzburg), Petros Avramopoulos(German Centre for Cardiovascular Research), Stefan Engelhardt(Heidelberg University), Jasmin Fendrich(Integrierte Forschungs- und Behandlungszentren), Karina Zimmer(Medizinische Hochschule Hannover), Thomas Dandekar(University of Würzburg), Meik Kunz(Orlando Immunology Center), Frank Weidemann(Katharinenhospital), Annette Just(Medizinische Hochschule Hannover), Regalla Kumarswamy(Centre for Cellular and Molecular Biology)
Cited by 361
Related Papers
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
MicroRNAs in the Human Heart
|Circulation|2007|888
Progressive hypertrophy and heart failure in β <sub>1</sub> -adrenergic receptor transgenic mice
|Proceedings of the National Academy of Sciences|1999|787
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767